|
News
-
06.27.2023IAM Patent 1000 Recognizes Perkins Coie and 51 Lawyers as Patent Leaders in U.S. and AsiaPress ReleasesPerkins Coie is pleased to announce that 51 of its intellectual property (IP) lawyers in the United States and Asia were recognized by Intellectual Asset Management (IAM) in the 2023 IAM Patent 1000 list.
-
8.10.2022IAM Patent 1000 Recognizes Perkins Coie and 49 Firm Attorneys as Patent Leaders in U.S. and ChinaPress ReleasesPerkins Coie is pleased to announce that 49 of its intellectual property (IP) attorneys in the United States and Asia were recognized by Intellectual Asset Management (IAM) in the 2022 IAM Patent 1000 list, which recognizes the world’s leading, best-in-class patent professionals in patent prosecution, licensing, and litigation. The firm was also ranked nationally in the United States and China and internationally overall for patent litigation, prosecution, and post-grant proceedings.
-
03.09.2022Perkins Coie Partner Christy McCullough Named to the 2021 Top 50 Women in PTAB Trials ListPress ReleasesPerkins Coie is pleased to announce that partner Christy McCullough have been named to the 2021 Top 50 Women in PTAB Trials list by the Patent Trial and Appeal Board (PTAB) Bar Association.
-
08.04.2021IAM Patent 1000 Recognizes Perkins Coie and 46 Firm Attorneys as Patent Leaders in US and ChinaPress ReleasesPerkins Coie is pleased to announce that 44 of its intellectual property (IP) attorneys were recognized by Intellectual Asset Management (IAM) in the 2021 IAM Patent 1000 list, which recognizes the world’s leading, best-in-class patent professionals in patent prosecution, licensing, and litigation.
-
11.12.2019Perkins Coie’s Christy McCullough Recognized Among Top Women Attorneys Before the Patent Trial and Appeal BoardPress ReleasesPerkins Coie is pleased to announce that Seattle Partner Christy McCullough has been recognized as one of the top 50 women attorneys who practice before the U.S. Patent and Trademark Office’s Patent Trial and Appeal Board (PTAB).
-
10.12.2018Perkins Coie Attorneys Mentioned in Law360 - Fed. Circ. Rules Teva's Copaxone Patents Are InvalidGeneral NewsDavid Anstaett, Shannon Bloodworth, Brandon White, Dan Bagatell, and Christina Jordan McCullough were mentioned in the Law360* article, "Fed. Circ. Rules Teva's Copaxone Patents Are Invalid," as representation for Mylan Pharmaceuticals Inc. Bloomberg also covered the decision in the article, "Teva Loses Appeal Over Four Patents for MS Drug Copaxone."
*Subscription-based publication -
10.12.2018Perkins Coie Client Win Reported by Mylan - Mylan Prevails in Copaxone® 40mg/mL Litigation Against Teva in U.S. Appellate CourtGeneral NewsPerkins Coie represented Mylan in its recent milestone Federal Circuit wins, relating to Glatiramer Acetate Injection 40mg/mL. The decision was reported in the Mylan article, "Mylan Prevails in Copaxone® 40mg/mL Litigation Against Teva in U.S. Appellate Court."
-
01.06.2015Perkins Coie Announces 2015 Partner ClassPress ReleasesPerkins Coie announced that 21 associates, counsel and senior counsel have been promoted to partner. “The members of Perkins Coie's 2015 partner class are talented, hard-working attorneys who embody the national strength and forward-looking growth of our firm,” said John Devaney, Perkins Coie's Firmwide Managing Partner.
